Supervised methadone consumption: Client issues and stigma

Substance Use and Misuse

Volumn 44, Issue 6, 2009, Pages 794-808

  Anstice, Susan ^a   Strike, Carol J ^a,b   Brands, Bruna ^a,c,d  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HEALTH CANADA   (Canada)

Author keywords

Methadone maintenance treatment; Pharmacy; Qualitative research; Stigma; Supervised consumption

Indexed keywords

METHADONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG DEPENDENCE; DRUG USE; FEMALE; HEALTH SERVICE; HUMAN; INTERVIEW; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; STIGMA;

ADULT; ANALGESICS, OPIOID; CANADA; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; METHADONE; MIDDLE AGED; MODELS, THEORETICAL; OPIOID-RELATED DISORDERS; PATIENTS; PHARMACEUTICAL SERVICES; STEREOTYPING;

EID: 67651245421     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080802483936     Document Type: Article

References (31)

1. Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., Mattick, R. P. (2005). An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28:321-329.
2. Brands, B., Marsh, D. C. (1997). Methadone maintenance treatment: A Canadian perspective. Canadian Medical Association Journal, 157(4):399-401.
3. Brands, B., Lester, M., Sproule, B., Kamen, H. (2004). Use of diverted methadone. The College on Problems of Drug Dependence, 66th Annual Scientific Meeting, San Juan, Puerto Rico, June 12-17, 2004.
4. College of Physicians and Surgeons of Ontario (CPSO) (2005). Methadone maintenance guidelines. Toronto: Author.
5. Daker-White, G. (1997). Drug users' access to community-based services. Health and Place, 3(4):217-228.
6. Fischer, B., Chin, A. T., Kuo, I., Kirst, M., Vlahov, D. (2002). Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. Substance Use and Misuse, 37(4):495-522.
7. Goffman, E. (1963). Stigma: notes on the management of spoiled identity. New York: Simon & Schuster.
8. Gourlay, J., Ricciardelli, L., Ridge, D. (2005). Users' experiences of heroin and methadone treatment. Substance Use and Misuse, 40:1875-1882.
9. Health Canada (2002a). Best practices: methadone maintenance treatment. Ottawa: Office of Canada's Drug Strategy, Health Canada.
10. Health Canada (2002b). Literature review: methadone maintenance treatment. Ottawa: Office of Canada's Drug Strategy, Health Canada.
11. Isaac, P., Kalvik, A., Brands, J., Janacek, E. (Eds.). (2004). Methadone maintenance: a pharmacist's guide to treatment (2nd ed.). Toronto: Centre for Addiction and Mental Health (CAMH).
12. Keen, J., Oliver, P. (2004). Commissioning pharmacological treatments for drug users: a brief review of the evidence base. Drugs: Education, Prevention and Policy, 11(2):149-156.
13. Latowsky, M., Kallen, E. (1997). Mainstreaming methadone maintenance treatment: the role of the family physician. Canadian Medical Association Journal, 157(4):395.
14. Lawrie, T., Matheson, C., Bond, C., Roberts, K. (2003). Pharmacy customers' views and experiences of using pharmacies which provide needle exchange services in Aberdeen and Glasgow, Scotland. International Journal of Drug Policy, 14:445-447.
15. Link, B., Phelan, J. (2001). Conceptualizing Stigma. Annual Review of Sociology, 27:363-385.
16. Lofland, J., Lofland, L. (1995). Analyzing social settings: a guide to qualitative observation and analysis (3rd ed.). Belmont, CA: Wadsworth.
17. Lovell, S., Sheridan, J., Harris, J., Best, D., Strang, J. (1998). Methadone maintenance clients and the acceptability of supervised consumption of methadone. Journal of Substance Use, 92-97.
18. Luger, L., Bathia, N., Alcorn, R., Power, R. (2000). Involvement of community pharmacists in the care of drug misusers: pharmacy-based supervision of methadone consumption. International Journal of Drug Policy, 11:227-234.
19. Matheson, C. (1998a). Privacy and stigma in the pharmacy: illicit drug users' perspectives and implications for pharmacy practice. Pharmaceutical Journal, 260(6992):639-641.
20. Matheson, C. (1998b). Views of illicit drug users on their treatment and behaviour in Scottish community pharmacies: implications for the harm-reduction strategy. Health Education Journal, 57(1):31-41.
21. Mattick, R. P., Breen, C., Kimber, J., Davoli, M. (2005). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, 4. Retrieved September 2007, from, http://www.cochrane.org/reviews/en/ab002209.html
22. Murphy, S., Irwin, J. (1992). "Living with the dirty secret": problems of disclosure for methadone maintenance clients. Journal of Psychoactive Drugs, 24(3):257-264.
23. Neale, J. (1998). Drug users' views of drug service providers. Health and Social Care in the Community, 6(5):308-317.
24. NIH Consensus Conference. (1998). Effective medical treatment of opiate addiction. Journal of Addictive Disorders, 18:5-21.
25. Ontario Ministry of Health and Long-Term Care. McGuinty government increasing access to methadone treatment. Retrieved from http://www.health.gov.on.ca/.
26. Paulus, I., Halliday, R. (1967). Rehabilitation and the narcotic addict. Canadian Medical Association Journal, 96:655-659.
27. QSR N6 (2002). QSR N6. Victoria, Australia: QSR International Pty. Ltd.
28. Samitca, S., Huissoud, T., Jeannin, A., Dubois-Arber. (2007). The role of pharmacies in the care of drug users: what has changed in 10 years; the case of a Swiss region. European Addiction Research, 13:50-56.
29. Sheridan, J., Barber, N. (1996). Drug misusers' experiences and opinions of community pharmacists and community pharmacy services. The Pharmaceutical Journal, 257:325-327.
30. Strauss, A., Corbin, J. (1998). Basics of qualitative research: techniques and procedures for developing grounded theory. Thousand Oaks, CA: Sage.
31. Ward, J., Mattick, R. P., Hall, W. (1998). Methadone maintenance and other opioid replacement therapies. Amsterdam: Harwood Academic.